Patents

US 12747452 B2: Interneuron-specific therapeutics for normalizing neuronal cell excitability and treating Dravet syndrome

Granted
2026-09-29
Filed
2020-01-27 application 17428538
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided are therapeutic virus vectors, particularly, recombinant adeno-associated virus (rAAV) vectors, designed to contain an enhancer sequence that specifically restricts expression of an effector gene (e.g., an SCN1A-encoding polynucleotide, Gq-DREADD-encoding polynucleotide, or PSAM-encoding polynucleotide) contained in the vector to PV-expressing GABAergic interneuron or to neuron cell populations in the brain. The rAAV vectors, compositions and methods thereof are useful for treating subjects afflicted with neuropathologies, seizures, pharmacologically-intractable forms of epilepsy including Dravet syndrome (DS), a form of infantile epilepsy associated with severe seizures, cognitive impairment and premature death, as the cause of DS involves loss of function of a sodium channel encoded by the SCN1A gene. The described vectors restore expression of effector genes to the appropriate interneuron or neuron cell populations with specificity and sensitivity, advantageously to address the root cause of the disease by restoring the excitation-inhibition balance by means of gene-therapy (with SCN1A) or pharmacogenetics.

Source: PTBLXML, file of 2026-09-29 (ipgb20260929.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE BROAD INSTITUTE, INC. 503 patentsUS company or organizationCambridge, MABROAD INSTITUTE INC Nonprofit FUZZY medium confidence: same name (governing-board words and legal endings aside) and statePTBLXML, file of 2026-09-29
PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2,238 patentsUS company or organizationCambridge, MAHarvard University College or university EXACT high confidence: through the nonprofit with the college's EIN (identical full name and state)
PRESIDENT & FELLOWS OF HARVARD COLLEGE Form D issuer EXACT high confidence: identical full name and state
PRESIDENT AND FELLOWS OF HARVARD COLLEGE Federal lobbying client EXACT high confidence: identical full name and state
PRESIDENT AND FELLOWS OF HARVARD COLLEGE Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-09-29
NEW YORK UNIVERSITY 967 patentsUS company or organizationNew York, NYNew York University College or university EXACT high confidence: identical full name and state
NEW YORK UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-09-29

Inventors

InventorPlacePatentsPerson pageSource
Jordane DimidschsteinCambridge, MA2PTBLXML, file of 2026-09-29
Gordon FishellCambridge, MA3PTBLXML, file of 2026-09-29
Orrin DevinskyNew York, NYPTBLXML, file of 2026-09-29

CPC categories

SubclassCategoryFirst groupSource
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N15/86PTBLXML, file of 2026-09-29
A61KPreparations for medical, dental or toiletry purposesA61K48/0058PTBLXML, file of 2026-09-29
C07KPeptidesC07K14/705PTBLXML, file of 2026-09-29

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.